179 related articles for article (PubMed ID: 36994786)
21. ABO-immune complex formation and impact on platelet function, red cell structural integrity and haemostasis: an in vitro model of ABO non-identical transfusion.
Zaffuto BJ; Conley GW; Connolly GC; Henrichs KF; Francis CW; Heal JM; Blumberg N; Refaai MA
Vox Sang; 2016 Apr; 110(3):219-26. PubMed ID: 26528766
[TBL] [Abstract][Full Text] [Related]
22. The role of ABO matching in platelet transfusion.
Heal JM; Rowe JM; McMican A; Masel D; Finke C; Blumberg N
Eur J Haematol; 1993 Feb; 50(2):110-7. PubMed ID: 8440356
[TBL] [Abstract][Full Text] [Related]
23. Impacts of ABO-incompatible platelet transfusions on platelet recovery and outcomes after intracerebral hemorrhage.
Magid-Bernstein J; Beaman CB; Carvalho-Poyraz F; Boehme A; Hod EA; Francis RO; Elkind MSV; Agarwal S; Park S; Claassen J; Connolly ES; Roh D
Blood; 2021 May; 137(19):2699-2703. PubMed ID: 33649761
[TBL] [Abstract][Full Text] [Related]
24. A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions.
Sintnicolaas K; Löwenberg B
Br J Haematol; 1996 Mar; 92(4):1005-10. PubMed ID: 8616059
[TBL] [Abstract][Full Text] [Related]
25. Transfusion of ABO-nonidentical platelets is not associated with adverse clinical outcomes in cardiovascular surgery patients.
Lin Y; Callum JL; Coovadia AS; Murphy PM
Transfusion; 2002 Feb; 42(2):166-72. PubMed ID: 11896330
[TBL] [Abstract][Full Text] [Related]
26. D+ platelet transfusions in D- patients: cause for concern?
Bartley AN; Carpenter JB; Berg MP
Immunohematology; 2009; 25(1):5-8. PubMed ID: 19856725
[TBL] [Abstract][Full Text] [Related]
27. Transfusion-related adverse events in the Platelet Dose study.
Kaufman RM; Assmann SF; Triulzi DJ; Strauss RG; Ness P; Granger S; Slichter SJ
Transfusion; 2015 Jan; 55(1):144-53. PubMed ID: 25065959
[TBL] [Abstract][Full Text] [Related]
28. Providing ABO-identical platelets and cryoprecipitate to (almost) all patients: approach, logistics, and associated decreases in transfusion reaction and red blood cell alloimmunization incidence.
Henrichs KF; Howk N; Masel DS; Thayer M; Refaai MA; Kirkley SA; Heal JM; Blumberg N
Transfusion; 2012 Mar; 52(3):635-40. PubMed ID: 21895675
[TBL] [Abstract][Full Text] [Related]
29. Impact of ABO incompatibility on engraftment and transfusion requirement after unrelated cord blood transplantation: a single institute experience in Japan.
Tomonari A; Takahashi S; Ooi J; Tsukada N; Konuma T; Kobayashi T; Sato A; Iseki T; Yamaguchi T; Tojo A; Asano S
Bone Marrow Transplant; 2007 Sep; 40(6):523-8. PubMed ID: 17646845
[TBL] [Abstract][Full Text] [Related]
30. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients.
Heal JM; Blumberg N; Masel D
Blood; 1987 Jul; 70(1):23-30. PubMed ID: 3474041
[TBL] [Abstract][Full Text] [Related]
31. ABO non-identical platelet transfusions, immune platelet refractoriness and platelet support.
Han MH; Badami KG
Br J Haematol; 2024 May; 204(5):2097-2102. PubMed ID: 38419302
[TBL] [Abstract][Full Text] [Related]
32. Dilution is not the solution: acute hemolytic transfusion reaction after ABO-incompatible pooled platelet transfusion.
Guarente J; Harach M; Gould J; Karp JK; Peedin AR
Immunohematology; 2019 Sep; 35(3):91-94. PubMed ID: 31621366
[TBL] [Abstract][Full Text] [Related]
33. ABO compatibility and platelet transfusions of alloimmunized thrombocytopenic patients.
Duguesnoy RJ; Anderson AJ; Tomasulo PA; Aster RH
Blood; 1979 Sep; 54(3):595-9. PubMed ID: 465731
[TBL] [Abstract][Full Text] [Related]
34. Association of Blood Donor Sex and Prior Pregnancy With Mortality Among Red Blood Cell Transfusion Recipients.
Edgren G; Murphy EL; Brambilla DJ; Westlake M; Rostgaard K; Lee C; Cable RG; Triulzi D; Bruhn R; St Lezin EM; Erikstrup C; Ullum H; Glynn SA; Kleinman S; Hjalgrim H; Roubinian NH;
JAMA; 2019 Jun; 321(22):2183-2192. PubMed ID: 31184739
[TBL] [Abstract][Full Text] [Related]
35. Necrotizing enterocolitis and mortality after transfusion of ABO non-identical blood.
Parvizian MK; Barty R; Heddle NM; Li N; McDougall T; Mukerji A; Fusch C; Solh Z
Transfusion; 2021 Nov; 61(11):3094-3103. PubMed ID: 34487551
[TBL] [Abstract][Full Text] [Related]
36. Association of ABO-mismatched platelet transfusions with morbidity and mortality in cardiac surgery.
Blumberg N; Heal JM; Hicks GL; Risher WH
Transfusion; 2001 Jun; 41(6):790-3. PubMed ID: 11399821
[TBL] [Abstract][Full Text] [Related]
37. Contribution of donor- and recipient-associated factors to allergic transfusion reactions to platelets.
Zheng Y; Pei D; Sweat L; Ryan M; Mestemacher MA; Gann M; Cheng C; Geiger TL
Transfusion; 2021 Mar; 61(3):744-753. PubMed ID: 33314235
[TBL] [Abstract][Full Text] [Related]
38. Transfusion of platelets containing ABO-incompatible plasma: a survey of 3156 North American laboratories.
Fung MK; Downes KA; Shulman IA
Arch Pathol Lab Med; 2007 Jun; 131(6):909-16. PubMed ID: 17550318
[TBL] [Abstract][Full Text] [Related]
39. ABO incompatibility does not affect transfusion requirements or clinical outcomes of unrelated cord blood transplantation after myeloablative conditioning for haematological malignancies.
Chen Y; Wan X; Cao Y; Wang H; Han D; Zhang Y; Yao W; Song K; Fan Q; Zhu X; Sun Z; Liu H
Blood Transfus; 2022 Mar; 20(2):156-167. PubMed ID: 34369864
[TBL] [Abstract][Full Text] [Related]
40. Factors that influence platelet recovery after transfusion: resolving donor quality from ABO compatibility.
Jiménez TM; Patel SB; Pineda AA; Tefferi A; Owen WG
Transfusion; 2003 Mar; 43(3):328-34. PubMed ID: 12675717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
